Filing Details
- Accession Number:
- 0001237899-20-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-03 16:05:51
- Reporting Period:
- 2020-04-01
- Accepted Time:
- 2020-04-03 16:05:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-01 | 1,200 | $30.63 | 14,297 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-01 | 63 | $478.77 | 14,234 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 69 | $479.00 | 14,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 58 | $480.28 | 14,107 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 62 | $482.09 | 14,045 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 124 | $483.58 | 13,921 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 3 | $484.14 | 13,918 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 137 | $488.76 | 13,781 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 201 | $489.48 | 13,580 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 70 | $491.65 | 13,510 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 134 | $492.45 | 13,376 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 174 | $493.24 | 13,202 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 37 | $494.16 | 13,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 68 | $497.99 | 13,097 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-04-01 | 1,200 | $0.00 | 1,200 | $30.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,180 | 2020-12-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,401 | Indirect | By 401(k) Plan |
| Common Stock | 1,897 | Indirect | By Trust |
| Common Stock | 509 | Indirect | by 2017 GRAT |
| Common Stock | 2,284 | Indirect | by 2018 GRAT |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 124 shares of Company stock on April 1, 2020 at prices ranging from $483.35 to $483.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
- Represents volume-weighted average price of sales of 137 shares of Company stock on April 1, 2020 at prices ranging from $488.57 to $488.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
- Represents volume-weighted average price of sales of 201 shares of Company stock on April 1, 2020 at prices ranging from $489.17 to $489.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
- Represents volume-weighted average price of sales of 134 shares of Company stock on April 1, 2020 at prices ranging from $492.07 to $492.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
- Represents volume-weighted average price of sales of 174 shares of Company stock on April 1, 2020 at prices ranging from $493.14 to $493.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2020 at each separate price.
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
